Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT05650060
Eligibility Criteria:
Inclusion Criteria:
* Adult male or female aged ≥ 18 years at index date
* Previous diagnosis of moderate to severe plaque psoriasis as hospital record with available baseline PASI at index date (date 0 to date -7 prior index date)
* Initiated treatment with secukinumab for moderate to severe plaque psoriasis during September 2017-April 2021
Exclusion Criteria:
\- Patients diagnosed with other forms of psoriasis other than plaque-type
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05650060
Study Brief:
Protocol Section:
NCT05650060